Status:
UNKNOWN
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
Lead Sponsor:
University Ghent
Collaborating Sponsors:
University Hospital, Ghent
Vrije Universiteit Brussel
Conditions:
Cardiovascular Diseases
Cardiovascular Disease Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease p...
Eligibility Criteria
Inclusion
- Patients presenting with a first prescription for one of the following drug classes: antihypertensive drugs (= low-ceiling diuretics, beta blocking agents (excl. non-selective beta-blocking agents), ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers), lipid-lowering drugs (= statins), antidiabetic drugs (= metformin, glucagon-like peptide-1 (GLP-1) analogues, sodium-glucose co-transporter 2 (SGLT2) inhibitors), or any combination thereof.
- Age 18 years or older
- Community-dwelling
Exclusion
- The drug is prescribed for a non-cardiovascular indication (e.g. beta-blocking agent for migraine prophylaxis)
- Communication with the patient is not possible (e.g. due to cognitive impairment, insufficient knowledge of Dutch or French language)
Key Trial Info
Start Date :
October 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT06142838
Start Date
October 3 2023
End Date
August 31 2024
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmaceutical Care Unit (Ghent University)
Ghent, Belgium